Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

Identifying differentially expressed genes usingfalse discovery rate controlling procedures

Anat Reiner‐Benaim, Daniel Yekutieli, Yoav Benjamini · Bioinformatics · 2003 · 1.8K citations · Full text

Life Sciences, Bioinformatics, Biostatistics +15

A Model-Based Background Adjustment for Oligonucleotide Expression Arrays

Zhijin Wu, Rafael A. Irizarry, Robert Gentleman et al. · Journal of the American Statistical Association · 2004 · 1.7K citations

Life Sciences, Biology, Biostatistics +13

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton et al. · New England Journal of Medicine · 2014 · 1.4K citations

Medicine, Dermatology, Immunology +13

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +17

Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch

Landon K. Oetjen, Madison R. Mack, Jing Feng et al. · Cell · 2017 · 1.1K citations · Full text

Life Sciences, Neurobiology, Neuroscience +12